Author Correction: Somatic chromosomal engineering identifies BCAN-NTRK1 as a potent glioma driver and therapeutic target

Nat Commun. 2018 Mar 13:9:16187. doi: 10.1038/ncomms16187.

Abstract

This corrects the article DOI: 10.1038/ncomms15987.

Publication types

  • Published Erratum